#United States #New York #class action lawsuit #Pomerantz LLP #Bath & Body Works

Pomerantz Law Firm Alerts Investors Regarding Bath & Body Works Class Action Lawsuit

A recent announcement from the Pomerantz Law Firm highlights a significant class action lawsuit against Bath & Body Works, Inc. (ticker: BBWI). This legal action primarily addresses potential securities fraud and other unlawful business practices conducted by the company and its leadership. Investors impacted by this situation are encouraged to come forward and engage with the lawsuit, adhering to the listed deadlines for participation.

The lawsuit arises from reports issued by Bath & Body Works on August 28, 2025, revealing a 55.8% year-over-year decline in earnings per diluted share, dropping to $0.30. This disappointing financial revelation missed the company's previously established earnings guidance by $0.03. Additionally, the company registered a 57.9% decrease in net income, recording merely $64 million for the quarter. As a direct consequence of this news, Bath & Body Works experienced a 6.9% decline in stock price, settling at $29.36 per share.

In a troubling continuation of this trend, on November 20, 2025, Bath & Body Works released its third-quarter financial results, indicating another year-over-year revenue decline of 1%. This outcome fell short of the company's projected growth guidance of 1-3%. Furthermore, the latest figures revealed a staggering 26% drop in net income, amounting to $77 million. Notably, the company's optimistic sales forecasts were substantially downgraded, shifting from a projected 1.5%-2.7% growth to predictions of negative high single digits. This troubling trajectory compounded the challenges faced by the firm.

The financial fallout was significant, with the stock price plummeting by 24.8% to $15.82 per share following the November report. In light of these developments, the firm has shifted its approach, citing in an investor presentation that its previous strategies aimed at customer growth had proven ineffective. This admission raises serious concerns about the company's direction and overall management effectiveness.

For those who have incurred losses in their investments in Bath & Body Works during the class period, important deadlines are approaching. Investors are advised to connect with Danielle Peyton at Pomerantz LLP by emailing [email protected] or by calling 646-581-9980 (toll-free at 888.4-POMLAW, Ext. 7980) to inquire about their rights to potentially become the Lead Plaintiff in this class action. Interested parties should provide their mailing address, telephone number, and details regarding the number of shares purchased when reaching out.

Founded by the esteemed Abraham L. Pomerantz, Pomerantz LLP is a notable name in corporate, securities, and antitrust litigation, drawing on over 85 years of experience in advocacy for victims of securities fraud and corporate misconduct. The firm has secured numerous multimillion-dollar settlements on behalf of class members and continues to uphold the legacy of fighting against corporate injustice.

For those affected, urgent action is necessary, as the deadline for submitting an application to lead the class action is set for March 16, 2026. More details regarding the lawsuit and how to join can be found on Pomerantz's official website at www.pomerantzlaw.com.

This situation serves as a crucial reminder about the potential risks involved in investing and the importance of being vigilant about corporate accountability.